Table: Shin Nippon Biomedical -2022/23 group results

Shin Nippon Biomedical Laboratories

08/05/2023 07:00

May 8 (Reuters)- 
          Shin Nippon Biomedical Laboratories Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Mar 31, 2023    Mar 31, 2022   Mar 31, 2024     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           25.09           17.75          30.10        11.90    
               (+41.4 pct)     (+17.5 pct)    (+20.0 pct)  (+15.0 pct) 
  Operating        5.25            4.20           4.85         1.83    
               (+25.0 pct)     (+65.9 pct)    (-7.5 pct)   (-20.8 pct) 
  Recurring        9.19            7.08           6.94         2.90    
               (+29.9 pct)     (+94.2 pct)    (-24.5 pct)  (-51.1 pct) 
  Net
  Net              6.06            7.13           4.51         1.99    
               (-15.0 pct)     (+94.6 pct)    (-25.6 pct)  (-55.0 pct) 
  EPS          145.56 yen      171.20 yen     108.33 yen    47.80 yen  
  Ann Div       50.00 yen       40.00 yen      50.00 yen               
  -Q2 Div       20.00 yen          NIL         20.00 yen               
  -Q4 Div       30.00 yen       40.00 yen      30.00 yen               
  
  NOTE - Shin Nippon Biomedical Laboratories Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2395.T